GB0324897D0 - Composition - Google Patents
CompositionInfo
- Publication number
- GB0324897D0 GB0324897D0 GB0324897A GB0324897A GB0324897D0 GB 0324897 D0 GB0324897 D0 GB 0324897D0 GB 0324897 A GB0324897 A GB 0324897A GB 0324897 A GB0324897 A GB 0324897A GB 0324897 D0 GB0324897 D0 GB 0324897D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0324897A GB0324897D0 (en) | 2003-10-24 | 2003-10-24 | Composition |
PCT/GB2004/004511 WO2005041922A2 (en) | 2003-10-24 | 2004-10-22 | Composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0324897A GB0324897D0 (en) | 2003-10-24 | 2003-10-24 | Composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0324897D0 true GB0324897D0 (en) | 2003-11-26 |
Family
ID=29595798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0324897A Ceased GB0324897D0 (en) | 2003-10-24 | 2003-10-24 | Composition |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0324897D0 (en) |
WO (1) | WO2005041922A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0609924A2 (en) * | 2005-05-18 | 2010-05-11 | Pulmatrix Inc | use of an aerosol formulation containing about 0.5 to 20% (w / w) of a salt selected from the group consisting of a magnesium salt, a calcium salt, an aluminum salt, a silicon salt, a salt scandium, a titanium salt, a vanadium salt, a chrome salt, a cobalt salt, a nickel salt, a copper salt, a manganese salt, a zinc salt, a tin salt, and a combination thereof, and pharmaceutical composition |
CN102497853B (en) | 2009-03-26 | 2018-03-23 | 普马特里克斯营业公司 | Treat the dry powder formulation and method of tuberculosis |
EP2464346A1 (en) | 2010-08-30 | 2012-06-20 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
EP2611438B1 (en) | 2010-08-30 | 2020-04-01 | Pulmatrix Operating Company, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
RU2017144619A (en) | 2010-09-29 | 2019-02-20 | Пулмэтрикс, Инк. | CASES OF SINGLE-VALVE METALS OF DRY POWDERS FOR INHALATIONS |
DK2621488T3 (en) | 2010-09-29 | 2019-03-04 | Pulmatrix Operating Co Inc | CATIONIC DRY POWDER |
CN109999013A (en) | 2012-02-29 | 2019-07-12 | 普马特里克斯营业公司 | Inhalable dry powder doses |
EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
WO2014165303A1 (en) | 2013-04-01 | 2014-10-09 | Pulmatrix, Inc. | Tiotropium dry powders |
BR112017021111A2 (en) * | 2015-04-01 | 2018-07-03 | Lupin Atlantis Holdings Sa | process for manufacturing dry powder mixtures |
RU2715687C2 (en) * | 2015-04-15 | 2020-03-02 | Филип Моррис Продактс С.А. | Powder inhaler and method for use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143440A (en) * | 1966-07-21 | 1969-02-19 | Merck & Co Inc | Inhalation aerosol preparation |
BR8007911A (en) * | 1979-12-06 | 1981-06-16 | Glaxo Group Ltd | PERFECTED INHALER |
SE448277B (en) * | 1985-04-12 | 1987-02-09 | Draco Ab | INDICATOR DEVICE WITH A DOSAGE DEVICE FOR MEDICINAL PRODUCTS |
US4811731A (en) * | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB9115740D0 (en) * | 1991-07-20 | 1991-09-04 | Smithkline Beecham Plc | Medicaments |
US6250300B1 (en) * | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
DK1150918T3 (en) * | 1999-02-03 | 2004-12-20 | Biosante Pharmaceuticals Inc | Process for the preparation of therapeutic calcium phosphate particles |
GB9911770D0 (en) * | 1999-05-21 | 1999-07-21 | Glaxo Group Ltd | Powder loading method |
-
2003
- 2003-10-24 GB GB0324897A patent/GB0324897D0/en not_active Ceased
-
2004
- 2004-10-22 WO PCT/GB2004/004511 patent/WO2005041922A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005041922A2 (en) | 2005-05-12 |
WO2005041922A3 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0305941D0 (en) | Composition | |
GB0302738D0 (en) | Composition | |
GB0324918D0 (en) | Composition | |
EP1613352A4 (en) | Micro-cluster compositions | |
GB0324897D0 (en) | Composition | |
HK1087034A1 (en) | Actacid composition | |
GB0322033D0 (en) | Composition | |
GB0318824D0 (en) | Novel composition | |
GB0305790D0 (en) | Novel Composition | |
GB0329597D0 (en) | Compositions | |
MY145151A (en) | Composition | |
GB0300602D0 (en) | Compositions | |
GB0309317D0 (en) | Composition | |
GB0324295D0 (en) | Composition | |
GB0306312D0 (en) | Composition | |
GB0316857D0 (en) | Compositions | |
GB0301869D0 (en) | Composition | |
GB0326815D0 (en) | Composition | |
GB0320018D0 (en) | Composition | |
GB0320863D0 (en) | Composition | |
GB0306315D0 (en) | Composition | |
GB0311465D0 (en) | Composition | |
GB0311810D0 (en) | Composition | |
GB0304747D0 (en) | Composition | |
GB0301669D0 (en) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |